ADBiotech Co., Ltd. (KOSDAQ:179530)
3,105.00
-55.00 (-1.74%)
Last updated: Jun 25, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
Biotechnology | 8.60B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Online Platforms | 1.88B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Consolidation Adjustment | -2.03M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Animal Medicines, Supplementary Food, Health Functional Foods Product | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Animal Medicines, Supplementary Food, Health Functional Foods Product Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Animal Medicines, Supplementary Food, Health Functional Foods Merchandise | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Animal Medicines, Supplementary Food, Health Functional Foods Merchandise Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Commission | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Commission Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Antibiotic and Vaccine Substitute | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Antibiotic and Vaccine Substitute Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
South Korea | 8.07B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
South Korea Growth | -2.45% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia | 2.40B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia Growth | 1.84% |
Log In |
Log In |
Log In |
Log In | Upgrade
|